BG
SGYP

BlackRock Group’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

BlackRock Group’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$539K Buy
88,424
+21,502
+32% +$112K ﹤0.01% 2329
2016
Q3 		$368K Buy
66,922
+32,513
+94% +$152K ﹤0.01% 2415
2016
Q2 		$130K Sell
34,409
-532
-2% -$1.8K ﹤0.01% 2708
2016
Q1 		$96K Buy
34,941
+14,201
+68% +$51.4K ﹤0.01% 2778
2015
Q4 		$118K Sell
20,740
-709
-3% -$4.32K ﹤0.01% 2645
2015
Q3 		$114K Buy
21,449
+5,012
+30% +$38.8K ﹤0.01% 2679
2015
Q2 		$136K Buy
+16,437
New +$79.7K ﹤0.01% 2677

Other funds holding SGYP

PC
Paulson & Co New York $2.58B AUM 68.51% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock Group's SGYP Position: Q4 2016 in Review

BlackRock Group increased its Synergy Pharmaceuticals, Inc Common Stock (SGYP) stake by 32% in Q4 2016, buying an estimated $112K and bringing the position to 88,424 shares worth $539K. The position accounts for ﹤0.01% of the portfolio, ranked #2329.

BlackRock Group first reported a position in SGYP in Q2 2015 and has held it in 7 quarters since. 156 funds tracked by Wall St. Rank hold SGYP as of Q4 2016.

  • BlackRock Group held 88,424 shares of Synergy Pharmaceuticals, Inc Common Stock worth $539K as of Q4 2016.
  • BlackRock Group bought 21,502 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2016, an estimated $112K.
  • Synergy Pharmaceuticals, Inc Common Stock made up ﹤0.01% of BlackRock Group's portfolio in Q4 2016, its #2329 holding.
  • BlackRock Group first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q2 2015 and has held it in 7 quarters since.
  • 156 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2016.

Based on BlackRock Group's 13F filing for Q4 2016, filed 10 Feb 2017.